Share Name Share Symbol Market Type Share ISIN Share Description
Abcam Plc LSE:ABC London Ordinary Share GB00B6774699 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -8.00 -0.58% 1,360.00 1,357.00 1,359.00 1,390.00 1,356.00 1,390.00 675,252 16:35:29
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 260.0 8.4 6.0 226.7 3,084

ABCAM PLC Director/PDMR Shareholding

12/03/2021 2:55pm

UK Regulatory (RNS & others)

Abcam (LSE:ABC)
Historical Stock Chart

From Dec 2020 to Jun 2021

Click Here for more Abcam Charts.


RNS Number : 1582S


12 March 2021

For immediate release

12 March 2021


("Abcam" or the "Company")

Director/PDMR Shareholding Notification

 1     Details of the person discharging managerial responsibilities/person 
        closely associated 
 a)    Name                             Mr Marc Perkins 
      -------------------------------  ---------------------------------------------------------- 
 2     Reason for the notification 
 a)    Position/status                  General Counsel and Company Secretary 
      -------------------------------  ---------------------------------------------------------- 
 b)    Initial notification             Initial notification 
      -------------------------------  ---------------------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
 a)    Name                             Abcam plc 
      -------------------------------  ---------------------------------------------------------- 
 b)    Legal Entity Identifier          213800B9N83DSNT33F79 
      -------------------------------  ---------------------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for (i) 
        each type of instrument; (ii) each type of transaction; (iii) 
        each date; and (iv) each place where transactions have been conducted 
 a)    Description of the financial     Ordinary shares of 0.2 pence each 
        instrument, type of 
        Identification code 
      -------------------------------  ---------------------------------------------------------- 
 b)    Nature of the transaction        Purchase of shares. 
      -------------------------------  ---------------------------------------------------------- 
 c)    Currency                         GBP 
      -------------------------------  ---------------------------------------------------------- 
 d)    Price(s) and volume(s)                 Price(s)                     Volume(s) 
                                       ---------------------  ----------------------------------- 
   GBP15.28575 per 
    share                                                      1,307 
  ---------------------                                       ----------------------------------- 
 e)    Aggregated information              Price(s)        Aggregated Volume(s)      Aggregated 
====  ===============================  ----------------                            -------------- 
     GBP15.28575                                1,307                               GBP19,978.48 
  ----------------  -------------------------------------------------------------  -------------- 
 f)    Date of the transaction          11 March 2021 
      -------------------------------  ---------------------------------------------------------- 
 g)    Place of the transaction         London Stock Exchange, AIM 
      -------------------------------  ---------------------------------------------------------- 

Forward-Looking Statements

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any express or implied statements contained in this announcement that are not statements of historical fact may be deemed to be forward-looking statements, including, without limitation, statements regarding award eligibility and LTIP issuance and value sufficiency under the laws of the United Kingdom, as well as statements that include the words "expect," "intend," "plan," "believe," "project," "forecast," "estimate," "may," "should," "anticipate" and similar statements of a future or forward-looking nature. Forward-looking statements are neither promises nor guarantees, but involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected, including, without limitation: a regional or global health pandemic, including the novel coronavirus ("COVID-19"), which has adversely affected elements of our business, could severely affect our business, including due to impacts on our operations and supply chains; challenges in implementing our strategies for revenue growth in light of competitive challenges; developing new products and enhancing existing products, adapting to significant technological change and responding to the introduction of new products by competitors to remain competitive; failing to successfully identify or integrate acquired businesses or assets into our operations or fully recognize the anticipated benefits of businesses or assets that we acquire; if our customers discontinue or spend less on research, development, production or other scientific endeavours; and the important factors discussed under the caption "Risk Factors" in Abcam's prospectus pursuant to Rule 424(b) filed with the U.S. Securities and Exchange Commission ("SEC") on 22 October 2020, which is on file with the SEC and is available on the SEC website at, as such factors may be updated from time to time in Abcam's other filings with the SEC. Any forward-looking statements contained in this announcement speak only as of the date hereof and accordingly undue reliance should not be placed on such statements. Abcam disclaims any obligation or undertaking to update or revise any forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise, other than to the extent required by applicable law.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

March 12, 2021 09:55 ET (14:55 GMT)

1 Year Abcam Chart

1 Year Abcam Chart

1 Month Abcam Chart

1 Month Abcam Chart
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210620 07:09:42